InORS - International Observational Registry on Schizophrenia With Injectable Risperidone and Oral Antipsychotics

CompletedOBSERVATIONAL
Enrollment

1,085

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Schizophrenia
Interventions
DRUG

Risperidone Long-Acting injectable or oral antipsychotics

According to label

Trial Locations (98)

Unknown

Brno

České Budějovice

Most

Olomouc

Prague

Přerov

Bar-le-Duc

Boulogne-Billancourt

Bourg-en-Bresse

Challans

Créteil

Dax

La Roche-sur-Yon

La Seyne-sur-Mer

Laxou

Marseille

Mont-Saint-Martin

Montpellier

Morlaix

Plouguernével

Rennes

Saint-Avé

Saint-Égrève

Sarreguemines

Verdun

Villejuif

Augsburg

Bad Honnef

Berlin

Bochum

Butzbach

Chemnitz

Coesfeld

Cologne

Dortmund

Dresden

Düsseldorf

Ebensfeld

Frankfurt

Fürth

Geithain

Greifswald

Grevenbroich

Hamburg

Ilmenau

Köthen

Krefeld

Leipzig

Limburg

Löhne

Magdeburg

Mannheim

München

Neuss

Oranienburg

Plauen

Potsdam

Riesa

Schleswig

Stolberg

Stralsund

Ulm

Velbert

Wetzlar

Wismar

Wuppertal

Arta

Athens

Chania

Crete

Ioannina

Larissa

Thessalonikis

Véroia

Kronshtadt

Nizhny Novgorod

Saint Petersburg

Yekaterinburg

Birmingham

Pretoria

A Coruña

Burgos

Getafe

Madrid

Monforte de Lemos

Salamanca

Valladolid

Vigo

Adana

Ankara

Erzurum

Eskişehir

Istanbul

Izmir

Kocaeli

Manisa

Mersin

Trabzon

Sponsors
All Listed Sponsors
lead

Janssen-Cilag International NV

INDUSTRY